IP Library Granted Patent US 9,849,189
Granted Patent B2
US 9,849,189 · App. 15/144,582 · Granted Dec 26, 2017

Targeted delivery of antimicrobial agents

Inventors: Barney Bishop (Annandale, VA); Monique van Hoek (Centreville, VA); Keith M. Davies (Haymarket, VA)
Assignee: George Mason Research Foundation, Inc.
A61K47/48246A61K31/15A61K31/165A61K31/5383A61K47/64A61K47/645
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,849,189
App. No.
15/144,582
Granted
Dec 26, 2017
Kind
B2
Abstract

A cationic antimicrobial peptide (CAMP) conjugate is disclosed. The CAMP conjugate may be made by identifying a suitable carrier peptide; identifying a suitable antimicrobial agent; creating a conjugate by conjugating the peptide with the antimicrobial agent; and evaluating and refining the conjugate. The peptide may be short peptide based on the sequence of a CAMP, such as human β-defensin-3. The peptide can be directly connected to the antimicrobial agent or through a linker segment. The antimicrobial agent may be connected to the peptide or the linker segment through stable or cleavable bonding. The peptide may carry and facilitate the delivery of the conjugated antimicrobial agent to a microbe.

Claims (11)

1. A method for delivering an antimicrobial agent to a microbe, comprising contacting the microbe with a cationic antimicrobial peptide (CAMP) conjugated to the antimicrobial agent, wherein the CAMP comprises the amino acid sequence RGRRSSRRKK (SEQ ID NO:3), and wherein the CAMP is connected to the antimicrobial agent directly or through a linker segment, the antimicrobial agent being connected to the CAMP or the linker segment through a stable or cleavable bond.

2. The method of claim 1 , wherein the CAMP comprises an amide group on the C-terminus.

3. The method of claim 1 , wherein the linker segment affixes the antimicrobial agent to the CAMP through acylation of the amino group of the N-terminus of the CAMP.

4. The method of claim 1 , wherein the antimicrobial agent is levofloxacin.

5. The method of claim 1 , wherein the antimicrobial agent is chloramphenicol.

6. The method of claim 1 , wherein the antimicrobial agent is a diazeniumdiolate.

7. The method of claim 1 , wherein the linker connects the antimicrobial agent to the CAMP via an amide bond between a carboxyl group of the linker and a side chain of a lysine residue of the CAMP.

8. The method of claim 1 , wherein the antimicrobial agent or the linker is attached to the CAMP via an amide bond formed with a primary amino group of at least one of the N-terminus of the CAMP and a lysine side chain of the CAMP.

9. The method of claim 1 , wherein the microbe is a bacteria.

10. The method of claim 1 , wherein the microbe is a fungus.

11. The method of claim 1 , wherein the microbe is a virus.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2016
From: BISHOP, BARNEY; DAVIES, KEITH M.; HOEK, MONIQUE VAN
To: GEORGE MASON UNIVERSITY
Reel/Frame 038442/0146 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2016
From: GEORGE MASON UNIVERSITY
To: GEORGE MASON INTELLECTUAL PROPERTIES, INC.
Reel/Frame 038442/0231 →
CHANGE OF NAME Recorded May 3, 2016
From: GEORGE MASON INTELLECTUAL PROPERTIES, INC.
To: GEORGE MASON RESEARCH FOUNDATION, INC.
Reel/Frame 038595/0809 →
Continuity (4)
Continuation 13757202 · Feb 1, 2013
Continuation 12502420 · Jul 14, 2009
Provisional Application 61081557 · Jul 17, 2008
Related Publication 20160367692A1 · Dec 22, 2016